Business Context and Reporting Period
This Form 6-K/A is a report of a foreign issuer filed by GlaxoSmithKline plc for the period ending February 2013. The filing serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, specifically regarding changes in share interests.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure of a specific share transaction rather than a financial performance report.
Material Changes
The material change disclosed is a transaction involving the acquisition of Ordinary Shares by a connected person:
- Connected Person: Mrs. K Thomson (connected to Director Mr. P C Thomson).
- Transaction Date: February 11, 2013.
- Price: 1,450.62 pence per Ordinary Share.
- Quantity: Acquisition of 2 Ordinary Shares under the personal contribution element and 2 Ordinary Shares under the matching element (Company contribution) of the ShareReward Plan.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the notification of the share transaction in accordance with Disclosure and Transparency Rule 3.1.4R(1)(c).
Investor Verification Points
- Verify the total shareholding of Mrs. K Thomson post-transaction to assess concentration of interest.
- Confirm the terms of the ShareReward Plan regarding the matching element contribution.
- Note that this filing does not contain financial performance data; refer to Form 20-F for comprehensive financial metrics.